I read somewhere Sinopharm vaccine was developed from the same method as Polio vaccine. Old school but proven.

Sharks playing waiting game. I already bought and paid for. Not adding or selling. Just dormant. In fact these days, pun tak larat to open my trading account to see Kanger price.

Well..we have another 2 weeks before end of December to know where we are heading. Prices seemed bottomed out between 170 to 175 for weeks. I am not worried at all.

There's no logic on Kstar at all. Even Caring would be a better choice.

UlarSawa, I think you can talk about bamboo, I talk about Vaccine, happy?

Very simple...Vaccine news is days away, Bamboo news is months away. Why report something which is months away? I would post whatever news is the latest.

After UAE registration on Sinopharm, China should be announcing their results officially shortly.

Some people had this entrenched mentality Chinese are backward. But until they gone there and see for themselves, they have no idea what they are talking about.

I think the Public Relation Department of Kanger need to up their game. Don't know how to do marketing.

PETALING JAYA: Health director-general Dr Noor Hisham Abdullah said the Covid-19 vaccine need not be halal in order to be administered in Malaysia, following concerns raised by a few quarters over the matter.

Speaking to The Straits Times, Noor Hisham however, said if the makers of the vaccine could obtain halal certification, it “would be better”.

https://www.msn.com/en-my/news/national/covid-19-vaccine-need-not-be-halal-according-to-health-dg-says-report/ar-BB1bMeHV?ocid=msedgntp

Dr Noor Hisham rubbishes report claiming Chinese vaccines unsafe
Keertan Ayamany 11 hrs ago

KUALA LUMPUR, Dec 9 ― Health director-general Tan Sri Dr Noor Hisham Abdullah today debunked new that vaccines made in China are unsafe to use, saying that the East Asian nation has a successful track record in manufacturing vaccines for diseases other than Covid-19.

Dr Noor Hisham was responding to a question by a journalist, who highlighted a news article that has been making the rounds over the past few days, alleging that vaccines manufactured in China are not safe

“The news is not true at all. If we see, China has come out with prequalified vaccines for the World Health Organisation (WHO), for example, vaccines for influenza, polio, hepatitis A, and japanese encephalitis.

“So they have experience with manufacturing vaccines,” he said during a press conference today.

He said that the issue now was the Covid-19 vaccine is new, which requires testing in three phases.

He highlighted that Malaysia has yet to receive any report on the third phase of testing for any of the Covid-19 vaccines developed globally.

Dr Noor Hisham previously said on December 4 that the Health Ministry will conduct its own third phase of clinical trials on a vaccine that is developed by the Institute of Medical Biology Chinese Academy of Medical Sciences in Beijing, China.

This decision was made after phases one and two of clinical trials in China showed that the vaccine is safe to use and garnered good results.

https://www.msn.com/en-my/news/national/dr-noor-hisham-rubbishes-report-claiming-chinese-vaccines-unsafe/ar-BB1bLXkq?ocid=msedgntp

Wait until 1QR 2021 la...my investments can wait.

This statement means gloves manufacturing venture is called off, I think.

"Backed by a healthy operating cash flow generated by its China operations, the Group has set its sights on establishing new revenue streams in Malaysia. Kanger recently purchased a parcel of land measuring 5.5 acres in Kuala Selangor for RM6.8 million. They are actively looking out for strategic opportunities with attractive prospects for the Group to invest in."

Even with news like this, prices won't move.

https://www.channelnewsasia.com/news/world/covid-19-uae-registers-china-sinopharm-vaccine-86-effective-13734198

This write up has pictures of 2 buildings ie Autocity and Hotel block which belong to Kanger. Very impressive write up.

http://newswavmaker.com/how-this-malaysian-listed-company-is-set-to-become-the-worlds-largest-bamboo-producer/

@Flying, no worries. I am way past love and hate in forums. Peace.

Still cannot make up your mind to "moving on already" or "keep coming back"?
Are you in love here?

@Flyingwithwings, I know you were talking about bamboo, but you guys keep ride on vaccine sentiments more. who are you kidding to focus on bamboo. just admit this counter is not worth it. i moving on already
09/12/2020 2:19 PM

I will keep coming with a good counter for those who dont make profits here. As usual
09/12/2020 2:45 PM

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

@Flying...tq for your comments. I will keep them close to my heart. And now you can fly away and not come back. Bye2

Buy or no buy Kanger never mind, at least you gain some knowledge whats going in the world around us. And next time you inspect your condo, you can ask developer, is this hardwood timber or bamboo flooring?

@Flying...obviously you are not bothered to follow our forum postings. We had always been consistent with bamboo core business and vaccine is the bonus. Either that or you choose to be ignorant. .

I see the future, if not I were got confidence to invest here? hehehe...

The worldwide market for Bamboo Flooring is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 1430 million US$ in 2024, from 1160 million US$ in 2019, according to a new GIR (Global Info Research) study.

@NPRA, I like your investing attitude..hahahaha

Me too. I am holding until next year probably after first quarter to see how it goes. I am not worried actually.

After KJ statement, easy to announce but not easy to approve, let alone import. What more is a shelf company without even registered for business.

"Untuk memudahkan penyimpanan, pengendalian dan pengedaran vaksin yang selamat, kumpulan bekerjasama dengan Zuellig Pharma Sdn Bhd (Zuellig Pharma), pengedar vaksin terbesar di Malaysia dan Asia.

"Zuellig Pharma adalah salah satu pemegang lesen yang diberikan kerajaan untuk pengedaran vaksin dan mempunyai kemampuan penyimpanan serta pengedaran.

Introducing ZUELLIG PHARMA

Kanger roped in Zuellig Pharma as its distributor for SINOPHARM VACCINE.

------------------------------------------------------------------------------------------------

MAKING HEALTHCARE MORE ACCESSIBLE

Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started almost a hundred years ago and has grown to become a US$13 billion business covering 13 markets with over 12,000 employees. Our people serve over 350,000 medical facilities and work with over 500 clients, including the top 20 pharmaceutical companies in the world.

More recently, we launched our Zuellig Health Solutions Innovation Centre to develop new services and address some pressing healthcare needs in Asia. Since then, our teams have been focused on creating data, digital and disease management solutions, supporting patients with chronic conditions and helping payors manage healthcare costs.

https://www.zuelligpharma.com/about-us

Just for knowledge:

7 Days Inn is a budget hotel chain in China and there are 4,600 of them as at 2018. And this is just one of many similar hotel chains.

https://en.wikipedia.org/wiki/7_Days_Inn

Posted by Noobie123 > Dec 9, 2020 8:49 AM | Report Abuse

Can you imagine how many small hotels are there in China? There are hundreds of towns and billions of people to cater for.

Can you imagine how many small hotels are there in China? There are hundreds of towns and billions of people to cater for.
--------------------------------------------------------------------------------

In 2018, the group secured the exclusive distributorship in China for the Classen brand of laminated hardwood flooring from Classen GmbH, Germany.

With rising acceptance of the Classen brand in China, Kanger was recently presented with the Excellence Award for Best Supplier to the Chinese Bed & Breakfast Industry at the 2019 International B&B Industry Development Forum and the 2019-2020 Illustrious Brand award by the China Renovation & Construction Alliance.

Sales of Classen products have been encouraging and proved to be a good complement to the group, generating revenue to the group whilst the group scaled down its production of in-house bamboo products to make way for the relocation exercise of the bamboo plant.

PETALING JAYA: ACE Market-listed Kanger International Bhd has signed 10-year lease agreements for two of its commercial buildings in Ganzhou City in China.

The initial rental income per year for both commercial buildings will amount to RM11.1mil, subject to scheduled rent increases, the company said in a statement.

The commercial buildings comprise a purpose-built six-storey one-stop “AutoCity” building with a net lettable area (NLA) of 493,062 sq ft and a 19-storey hotel with 190,715 sq ft of NLA.

Both buildings are owned by Kanger’s indirect wholly-owned subsidiary, Ganzhou Kanger Industrial Co Ltd and have a combined NLA of 683,777 sq ft, the statement added.

https://www.thestar.com.my/business/business-news/2020/03/10/kanger-inks-lease-deals-in-china

Kanger to facilitate sand exports to mainland China, Hong Kong

https://www.theedgemarkets.com/article/kanger-facilitate-sand-exports-mainland-china-hong-kong

Kanger, SSB collaborate to market antimicrobial coating solutions in Malaysia, globally

https://www.nst.com.my/business/2020/07/605182/kanger-ssb-collaborate-market-antimicrobial-coating-solutions-malaysia

Of late there are so many new comers to this Kanger forum asking so many questions. You all would realise we do not ask people to buy, sell or cut loss. We just state facts and if at all provide links for all to read up. This is what and who Kanger supporters are.

Or shall we refrain from posting facts and go into speculative mode?
Up ah, Huat ah, Buy now if not regret, Something big is coming, wait for announcement....(Goreng, Goreng ...I am just joking, okie)

Happy trading..hopefully prices go up today, seriously. :)

Kstar is not the sole distributor for vaccine but appointed by sole distributor as sales agent. I see no reason why cannot sell as it has nothing to do with approvals. The sole distributor Kanger already given letter by Mosti to deal direct with Sinopharm but still need final approval by NPRA.

But I agree this counter share price is very bad.

Cry no tears..

Agreed....I will log out too

Cos it is not a goreng counter

@eyeHunter...you look at the low volumes, you already know Kanger investors are holding strong when all vaccine counters facing waterfall. It is cruel to ask people to cut loss. Don't even try suggesting here and waste your time here.

The government has already placed orders for several million shots of vaccine from three manufacturers: Pfizer/BioNTech, AstraZeneca, and Moderna.

Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus vaccines ordered by the government.

The regulator said important data on safety, efficacy and quality are still missing. It has reached out to the manufacturers, who provided data from their studies.

“We lack data on the effectiveness of the clinical trials and on the important subgroups that participated in these large studies,” said Claus Bolte, head of the authorisation division at Swissmedic, at a press briefing on Tuesday organised by the Federal Office of Public Health.

For example, Swissmedic wants to know about the pre-existing illnesses of the people who took part in these studies. According to the regulator, acceptance of such rapidly developed vaccines requires a high degree of trust in manufacturers and approving authorities. It is therefore important to examine very closely the effects on different groups of people.

Ular...story already closed. No need to speculate any more.

No la...we no fight here. Just making fun of each another. Wat for angry? What can you do if price go down? Laugh and it will be another day.

@eyeHunter...you sell all and still come here. You must really love the culture, climate and wonderful investors here. Buy la at least 1000 shares..at least that will make you one of us and your legit presence here.

Actually nothing wrong in promoting vaccine here, afterall Kanger is the first one to go into vaccine. Kanger already got recognised by Mosti, , no goreng artificially, no huge pump and dump. Why worry?

@eyehunter, you never give up here. You keep coming. Are you in love with Kanger ah?

Only Kanger got MOSTI letter to import vaccine. All others kaput.

@18K...yes...rileks aje

Bamboo is the core business. It will continue. Vaccine is a money making opportunity. It will not last long.

Those goreng without fundamentals will get burnt. Pity those who chased high.

Kanger already got Mosti letter, So not affected by what KJ said in parliament.